Financial statements Jg Pharm Katarzyna Jaśkowiec
Balance sheet data of JG PHARM KATARZYNA JAŚKOWIEC
|
Year
|
2020
|
2021
|
2023
|
|---|---|---|---|
| Total assets | 1 827 536,30 | 1 467 264,39 | 1 840 189,53 |
| A. Fixed assets | 18 712,60 | 17 167,56 | 2 811,25 |
| B. Current assets | 1 808 823,70 | 1 450 096,83 | 1 837 378,28 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
| Total liabilities | 1 827 536,30 | 1 467 264,39 | 1 840 189,53 |
| A. Equity | 655 781,28 | 432 927,55 | 611 433,08 |
| B. Liabilities and provisions for liabilities | 1 171 755,02 | 1 034 336,84 | 1 228 756,45 |
| I. Long-term liabilities | 375 987,00 | 51 711,42 | 0,00 |
| II. Short-term liabilities | 619 612,55 | 842 237,92 | 1 228 756,45 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.
AD
AD